Clinical Trial Update: JS001 Combined With TP as First-line Treatment for Unresectable or Advanced Small Cell Esophageal Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update announcing JS001 in combination with TP as first-line therapy for unresectable or advanced esophageal small cell carcinoma, with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small-cell Carcinoma of the Esophagus

Drugs mentioned

• JS001 (PD-1 inhibitor)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Esophageal Small Cell Carcinoma | Phase 2 | Status: RECRUITING